79 related articles for article (PubMed ID: 23866030)
1. The expression of SOX9, Tiam1, and PTEN is correlated with angiogenesis and prognosis in gastric cancer.
Lei L; He L; Chen K; Lv Z
Transl Cancer Res; 2020 Jun; 9(6):3998-4004. PubMed ID: 35117766
[TBL] [Abstract][Full Text] [Related]
2. Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.
Zhou F; Wei H; Ding A; Qiu W; Feng L; Zhou Q; Liang J; Yue L
Clin Transl Sci; 2013 Oct; 6(5):381-5. PubMed ID: 24127926
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Bhaskari J; Bhagat R; Shilpa V; Premalata CS; Krishnamoorthy L
J Ovarian Res; 2024 Apr; 17(1):77. PubMed ID: 38594780
[TBL] [Abstract][Full Text] [Related]
4. Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinoma.
Cheng H; Wang W; Zhang Y; Zhang B; Cheng J; Teng P; Tang X
Oncol Lett; 2017 Jul; 14(1):159-164. PubMed ID: 28693148
[TBL] [Abstract][Full Text] [Related]
5. MiR-410-3p suppresses primary gastric cancer and exosomes regulate endogenous expression of miR-410-3p.
Liu MX; Chu KM
Am J Cancer Res; 2023; 13(6):2670-2680. PubMed ID: 37424822
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma.
Li L; Beeraka NM; Xie L; Dong L; Liu J; Wang L
Discov Oncol; 2022 Jul; 13(1):64. PubMed ID: 35829833
[TBL] [Abstract][Full Text] [Related]
7. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.
Zhou C; Yang Q
J Int Med Res; 2021 Mar; 49(3):300060521993312. PubMed ID: 33682495
[TBL] [Abstract][Full Text] [Related]
8. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
9. Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis.
Liu Y; Ren W; Bai Y; Wan L; Sun X; Liu Y; Xiong W; Zhang YY; Zhou L
J Nat Med; 2018 Mar; 72(2):481-492. PubMed ID: 29350326
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
11. Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.
Liikanen I; Koski A; Merisalo-Soikkeli M; Hemminki O; Oksanen M; Kairemo K; Joensuu T; Kanerva A; Hemminki A
Oncoimmunology; 2015 Mar; 4(3):e989771. PubMed ID: 25949903
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.
Da MX; Zhang YB; Yao JB; Duan YX
Braz J Med Biol Res; 2014 Dec; 47(12):1021-8. PubMed ID: 25387667
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients.
Li Y; Sun Z; Liu K; Qiu W; Yao R; Feng T; Xin C; Yue L
Mol Clin Oncol; 2014 Nov; 2(6):1055-1061. PubMed ID: 25279197
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
Zhao CB; Bao JM; Lu YJ; Zhao T; Zhou XH; Zheng DY; Zhao SC
Am J Cancer Res; 2014; 4(4):369-77. PubMed ID: 25057439
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear quantitative radiation sensitivity prediction model based on NCI-60 cancer cell lines.
Zhang C; Girard L; Das A; Chen S; Zheng G; Song K
ScientificWorldJournal; 2014; 2014():903602. PubMed ID: 25032244
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 in health and disease.
Kang R; Chen R; Zhang Q; Hou W; Wu S; Cao L; Huang J; Yu Y; Fan XG; Yan Z; Sun X; Wang H; Wang Q; Tsung A; Billiar TR; Zeh HJ; Lotze MT; Tang D
Mol Aspects Med; 2014 Dec; 40():1-116. PubMed ID: 25010388
[TBL] [Abstract][Full Text] [Related]
17. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
